Dr. Tuesdae Renae Stainbrook, DO

Dr. Stainbrook practices at Trucare Internal Medicine & Infectious Diseases in Du Bois, Pennsylvania.

Dr. Stainbrook's NPI, 1588670285, was assigned on August 1, 2006. Dr. Stainbrook graduated from Ohio University, College of Osteopathic Medicine in 1995. Dr. Stainbrook holds Pennsylvania license OS-009811-L.

Dr. Stainbrook's primary practice is Trucare Internal Medicine & Infectious Diseases, at 135 Midway Dr, Du Bois, PA 15801 in Clearfield County. The practice phone is (814) 371-2348.

Dr. Stainbrook's primary practice is Trucare Internal Medicine & Infectious Diseases in Du Bois, Pennsylvania. Dr. Stainbrook is also affiliated with Penn Highlands DuBois. The medical group on file is TruCare Internal Medicine & Infectious Diseases. Dmand AI also links Dr. Stainbrook to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stainbrook practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Stainbrook's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Stainbrook is licensed in Pennsylvania.

CMS data shows 35,889 Medicare services from Dr. Stainbrook across 55 procedure codes in 2024, for 945 Medicare patients. Medicare paid $528,550 for them. Every service was in an office.

CMS counts 945 Medicare patients who saw Dr. Stainbrook in 2024. The largest group is 65 to 74, with 419 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stainbrook's median patient age at 65, with 48% women.

In 2024, Dr. Stainbrook wrote 2,015 Medicare Part D claims for 218 patients. 75% of them were for generic drugs. CMS names the drug for 1,476 of them, across 60 drugs with 11 or more claims each, at $1,087,400 in total drug cost. In 2023, CMS named 1,602 claims across 63 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Stainbrook for performance year 2024, reported as part of a group. Dr. Stainbrook accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stainbrook as offering telehealth. CMS counts 365 procedures of removal of tissue by Dr. Stainbrook, more than 95% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,921 general payments to Dr. Stainbrook from 79 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 64% of the total. Gilead Sciences, Inc. paid the most, $174,071.

Dr. Stainbrook graduated from Ohio University, College of Osteopathic Medicine in 1995.